Karmiel, Israel

Irena Oleinik

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Irena Oleinik: A Trailblazer in Topical Drug Formulations

Introduction

Irena Oleinik, an innovative inventor based in Karmiel, Israel, has made significant contributions to the field of pharmaceutical formulations. With a robust portfolio that includes four patents, Oleinik's work is particularly focused on the development of topical formulations using Montelukast, a widely recognized medication.

Latest Patents

Irena Oleinik's latest patents showcase her expertise in creating effective topical Montelukast formulations. One notable patent details a topical emulsion containing about 0.5% to about 10% Montelukast or its pharmaceutically acceptable salt, along with 0.4% to 4% carbomer. This formulation boasts particles with a D90 of less than 50 μm, ensuring that the Montelukast is uniformly dispersed in an emulsion with a pH range of 3.0 to 6.5. Additionally, she has developed a topical gel formulation featuring 0.5% to 10% Montelukast, 0.2% to 8% cellulose polymer, and 80% to 95% amphiphilic compounds, with water content kept below 4%. Such innovative formulations provide new avenues for drug delivery and treatment options.

Career Highlights

Irena Oleinik is prominently associated with Taro Pharmaceutical Industries Limited, where her inventions have played a critical role in advancing the company's product offerings. Her dedication to research and development in the field of pharmaceuticals has positioned her as a key figure in her field.

Collaborations

Throughout her career, Irena has collaborated with talented individuals in the industry, including coworkers Avi Avramoff and Helena Shifrin. These partnerships have enriched her work and contributed to successful innovations in drug formulations.

Conclusion

Irena Oleinik stands out as a pioneering inventor in the pharmaceutical sector, continually working to enhance topical drug delivery systems. Her contributions not only demonstrate her commitment to innovation but also highlight the potential for improved therapeutic outcomes through advanced formulation techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…